Speaker(s): Dr. Winn Chatham, Rheumatologist Professor of Medicine, University of Alabama, Louis W Heck Clinical Scholar in Rheumatology Birmingham, AL, USA and Dr. Joanne Bargman, Nephrologist, Professor of Medicine, University of Toronto Co-Director, UHN Network Renal-Rheumatology Lupus Clinic, Toronto, ON, Canada

Program Learning objectives:

• Identify the patients at risk for poor outcomes lupus nephritis.
• Understand the evolving role of calcineurin inhibitors in improving responses to induction therapy for lupus nephritis.
• Understand the role of neutralizing BAFF in decreasing renal flares and improving long-term outcomes in lupus nephritis.
• Understand the potential role of type-1 interferons in the pathogenesis of lupus nephritis